Glaukos has secured EU Medical Device Regulation (EU-MDR) certification for its iStent infinite, along with other MIGS ...

2 million individuals in the US live with type 1 diabetes and a rising number of type 2 patients require basal-bolus insulin therapy. Credit: Halfpoint via Shutterstock. The integration of Abbott’s ...

Nanostics has secured funding from Genome Canada and Genome Alberta to expedite the ClarityDX Prostate test integration into ...

Spiders can be an uncomfortable presence for many people but thanks to a new development, their silk is set to enhance nerve ...

In the trial, patients experienced a 24-point improvement in their Kansas City Cardiomyopathy Questionnaire score. Credit: Jo Panuwat D / Shutterstock. Foldax has revealed one-year outcomes from the ...

Medical Research Council (MRC) has launched a new £50m ($68.6m) centre spread across collaborator sites in the UK to develop ...

A professor from the University of Sheffield has received over £0.39m ($0.45m) in funding from Breast Cancer Now to develop a ...

Enterra Medical has commenced the randomised, multi-centre NAVIGATE study, designed to assess Gastric Electrical Stimulation ...

Vivasure Medical has submitted an application seeking premarket approval from the FDA for its PerQseal Elite vascular closure ...

The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.

Carlsmed looks set to join the 2025 class of medtechs going public, though it has not yet set its share price range.

ITM and Swiss-based Debiopharm have announced the imaging of the first subject in a new study arm (Part D) of the Phase I/II ...